{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:09:41Z","timestamp":1792174181241,"version":"4.4.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032627","name":"Military Institute of Science and Technology","doi-asserted-by":"publisher","award":["RS-2025\\u201300562636"],"award-info":[{"award-number":["RS-2025\\u201300562636"]}],"id":[{"id":"10.13039\/100032627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2020-NR049591"],"award-info":[{"award-number":["RS-2020-NR049591"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.phrs.2025.108015","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:00:00Z","timestamp":1761843600000},"page":"108015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Metabolic modulation of CD8\u207a T cells by metformin: A promising adjuvant strategy for CD8\u207a T Cell-Based Immunotherapies"],"prefix":"10.1016","volume":"222","author":[{"given":"Quynh Chau","family":"Ton Nu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4057-1313","authenticated-orcid":false,"given":"Pil-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.108015_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116909","article-title":"CD8+ T cell-based immunotherapy: promising frontier in human diseases","volume":"237","author":"Ton Nu","year":"2025","journal-title":"Biochem. Pharm."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular metabolism regulates the differentiation and function of T-cell subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.metabol.2018.11.010","article-title":"Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPK\u03b1","volume":"91","author":"Yan","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.phrs.2025.108015_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106114","article-title":"Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications","volume":"177","author":"Feng","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.108015_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1022739","article-title":"Metformin: Activation of 5\u2032 AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action","volume":"13","author":"Goel","year":"2022","journal-title":"Front. Genet"},{"key":"10.1016\/j.phrs.2025.108015_bib6","doi-asserted-by":"crossref","first-page":"2651790","DOI":"10.1155\/2022\/2651790","article-title":"The effects of 6 common antidiabetic drugs on anti-PD1 immune checkpoint inhibitor in tumor treatment","volume":"2022","author":"Zhan","year":"2022","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2025.108015_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fendo.2020.00191","article-title":"Metformin and its benefits for various diseases","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"10","key":"10.1016\/j.phrs.2025.108015_bib8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8+ T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib9","first-page":"2287","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp. Mol. Med. 2023 5511"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2025.108015_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00281-019-00744-5","article-title":"CD8+ T cell exhaustion","volume":"41","author":"Kurachi","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.phrs.2025.108015_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708908","article-title":"PI3K in T Cell Adhesion and Trafficking","volume":"12","author":"Johansen","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.phrs.2025.108015_bib14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1\u03b1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ni.2570","article-title":"Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity","volume":"14","author":"Kidani","year":"2013","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2013.10.007","article-title":"Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation","volume":"39","author":"Yao","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/immadv\/ltae009","article-title":"Hyperactivation of the PI3K pathway in inborn errors of immunity: current understanding and therapeutic perspectives","volume":"4","author":"Ijspeert","year":"2024","journal-title":"Immunother. Adv."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation","volume":"35","author":"Wang","year":"2011","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular metabolism regulates the differentiation and function of T-cell subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.913184","article-title":"TGF\u03b2 limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells","volume":"13","author":"Hope","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-52666-y","article-title":"GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency","volume":"15","author":"Guerrero","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib22","doi-asserted-by":"crossref","first-page":"a037770","DOI":"10.1101\/cshperspect.a037770","article-title":"Metabolic control of memory T-Cell generation and stemness","volume":"13","author":"Raynor","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2025.108015_bib23","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.celrep.2019.10.032","article-title":"NIX-mediated mitophagy promotes effector memory formation in antigen-specific CD8+ T cells","volume":"29","author":"Gupta","year":"2019","journal-title":"Cell Rep."},{"issue":"25","key":"10.1016\/j.phrs.2025.108015_bib24","doi-asserted-by":"crossref","first-page":"23433","DOI":"10.1074\/jbc.C500169200","article-title":"Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency","volume":"280","author":"Long","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41423-024-01224-z","article-title":"Regulation of CD8+ T cells by lipid metabolism in cancer progression","volume":"21","author":"Tang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-42634-3","article-title":"Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1\u03b1-mediated glycolytic reprogramming","volume":"14","author":"Wu","year":"2023","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.phrs.2025.108015_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157400","article-title":"Mitochondrial metabolism in T-cell exhaustion","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","article-title":"CD8+ T cell metabolism in infection and cancer","volume":"21","author":"Reina-Campos","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib29","doi-asserted-by":"crossref","first-page":"1046102","DOI":"10.3389\/fonc.2022.1046102","article-title":"Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: Predict before protect","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2025.108015_bib30","doi-asserted-by":"crossref","first-page":"1002297","DOI":"10.37349\/etat.2025.1002297","article-title":"Metabolic mechanisms of immunotherapy resistance","volume":"6","author":"Cabez\u00f3n-Guti\u00e9rrez","year":"2025","journal-title":"Explor. Target. AntiTumor Ther."},{"issue":"9","key":"10.1016\/j.phrs.2025.108015_bib31","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib33","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.immuni.2016.01.021","article-title":"Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells","volume":"44","author":"Kawalekar","year":"2016","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000501","article-title":"Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma","volume":"8","author":"Liu","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"16","key":"10.1016\/j.phrs.2025.108015_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138729","article-title":"CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation","volume":"5","author":"Beckermann","year":"2020","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib36","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20171068","article-title":"4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses","volume":"215","author":"Menk","year":"2018","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib37","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.4049\/jimmunol.165.11.6193","article-title":"Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response","volume":"165","author":"Cannons","year":"2000","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ccell.2015.09.004","article-title":"Structural design of engineered costimulation determines tumor rejection kinetics and persistence of CAR T cells","volume":"28","author":"Zhao","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib39","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ccell.2019.12.014","article-title":"THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-mediated priming of chimeric antigen receptor-redirected T cells","volume":"37","author":"Sun","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib40","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1172\/JCI133215","article-title":"Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability","volume":"130","author":"Guedan","year":"2020","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41375-017-0008-6","article-title":"PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells","volume":"32","author":"Zheng","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1 + PD-1 + CD8 + T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.phrs.2025.108015_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib44","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2016.05.002","article-title":"Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family","volume":"44","author":"Schildberg","year":"2016","journal-title":"Immunity"},{"issue":"21","key":"10.1016\/j.phrs.2025.108015_bib45","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.1128\/MCB.25.21.9543-9553.2005","article-title":"CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms","volume":"25","author":"Parry","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148546","article-title":"Targeting memory T cell metabolism to improve immunity","volume":"132","author":"Corrado","year":"2022","journal-title":"J. Clin. Invest"},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib47","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","article-title":"Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity","volume":"22","author":"Guo","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib48","article-title":"The role of metabolic dysfunction in T-cell exhaustion during chronic viral infection","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173934","article-title":"Metformin turns 62 in pharmacotherapy: emergence of non-glycaemic effects and potential novel therapeutic applications","volume":"898","author":"Mbara","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2025.108015_bib50","first-page":"1","article-title":"Metformin","author":"Bethesda","year":"2025","journal-title":"LiverTox Clin. Res. Inf. DrugInduc. Liver Inj."},{"key":"10.1016\/j.phrs.2025.108015_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1327814","article-title":"Metformin: update on mechanisms of action on liver diseases","volume":"10","author":"Ruan","year":"2023","journal-title":"Front. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/cpt.3639","article-title":"Quantitative contributions of hepatic and renal organic cation transporters to the clinical pharmacokinetic cimetidine\u2013metformin interaction","volume":"118","author":"Ailabouni","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2025.108015_bib53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib54","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.3390\/ijms25115869","article-title":"Harnessing metformin\u2019s immunomodulatory effects on immune cells to combat breast cancer","volume":"25","author":"Petrovic","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189262","article-title":"Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies","volume":"1880","author":"Li","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.108015_bib56","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.3389\/fimmu.2020.02056","article-title":"Immunomodulatory and antiviral activity of metformin and its potential implications in treating coronavirus disease 2019 and lung injury","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3904\/kjim.2021.363","article-title":"Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease","volume":"37","author":"Kim","year":"2021","journal-title":"Korean J. Intern. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib58","first-page":"655","article-title":"Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK\/mTOR\/NLRP3 inflammasome singling pathway","volume":"11","author":"Qing","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"9","key":"10.1016\/j.phrs.2025.108015_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002954","article-title":"Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2\/mTORC1\/p62 axis in tumor-infiltrating CD8T lymphocytes","volume":"9","author":"Nishida","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib60","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2025.108015_bib61","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002954","article-title":"Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2\/mTORC1\/p62 axis in tumor-infiltrating CD8T lymphocytes","volume":"9","author":"Nishida","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002614","article-title":"Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy","volume":"9","author":"Munoz","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12979-023-00394-0","article-title":"The effect of metformin on senescence of T lymphocytes","volume":"20","author":"Yang","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.phrs.2025.108015_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864225","article-title":"Nutrient condition in the microenvironment determines essential metabolisms of CD8+ T cells for enhanced IFN\u03b3 production by metformin","volume":"13","author":"Chao","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib65","doi-asserted-by":"crossref","first-page":"2100285","DOI":"10.1002\/bies.202100285","article-title":"The solid tumor microenvironment\u2014Breaking the barrier for T cells","volume":"44","author":"Simsek","year":"2022","journal-title":"BioEssays"},{"key":"10.1016\/j.phrs.2025.108015_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.eclinm.2021.101134","article-title":"The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: a systematic review and meta-analysis","volume":"41","author":"Li","year":"2021","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.phrs.2025.108015_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175592","article-title":"Metformin enhances T lymphocyte anti-tumor immunity by increasing the infiltration via vessel normalization","volume":"944","author":"Li","year":"2023","journal-title":"Eur. J. Pharm."},{"issue":"OCT","key":"10.1016\/j.phrs.2025.108015_bib68","article-title":"Metformin clinical trial in HPV+ and HPV-head and neck squamous cell carcinoma: Impact on cancer cell apoptosis and immune infiltrate","volume":"8","author":"Curry","year":"2018","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"15","key":"10.1016\/j.phrs.2025.108015_bib70","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1182\/bloodadvances.2023010740","article-title":"AMPK drives both glycolytic and oxidative metabolism in murine and human T cells during graft-versus-host disease","volume":"8","author":"Ramgopal","year":"2024","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.phrs.2025.108015_bib71","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.18632\/oncotarget.3501","article-title":"Deficiency of AMPK in CD8+ T cells suppresses their anti-tumor function by inducing protein phosphatase-mediated cell death","volume":"6","author":"Rao","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib72","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19095-z","article-title":"Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits","volume":"11","author":"B\u00f6hme","year":"2020","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2025.108015_bib74","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","article-title":"Metformin enhances the antitumor activity of CD8+ T lymphocytes via the AMPK\u2013miR-107\u2013eomes\u2013PD-1 pathway","volume":"204","author":"Zhang","year":"2020","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib75","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.celrep.2016.11.037","article-title":"Human stem cell-like memory T cells are maintained in a state of dynamic flux","volume":"17","author":"Ahmed","year":"2016","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib76","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230449","article-title":"Eomes-dependent mitochondrial regulation promotes survival of pathogenic CD4+ T cells during inflammation","volume":"221","author":"Joulia","year":"2024","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.phrs.2025.108015_bib77","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1633235","article-title":"Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy","volume":"8","author":"Verdura","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phrs.2025.108015_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01013","article-title":"Metabolic Reprogramming in CD8+ T Cells During Acute Viral Infections","volume":"11","author":"Gupta","year":"2020","journal-title":"Front. Immunol."},{"issue":"ement_1","key":"10.1016\/j.phrs.2025.108015_bib79","article-title":"Metformin treatment of CD8 T cells decreases pro-inflammatory cytokine production and shifts their metabolic state toward oxidative metabolism","volume":"210","author":"Molloy","year":"2023","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib80","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.1701041","article-title":"Metabolic Barriers to T Cell Function in Tumors","volume":"200","author":"Sugiura","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2025.108015_bib83","article-title":"Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Patsoukis","year":"2015","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2025.108015_bib85","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cmet.2022.06.008","article-title":"Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8+ T cells","volume":"34","author":"Elia","year":"2022","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib86","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib87","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib89","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib90","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cmet.2019.04.002","article-title":"Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment","volume":"30","author":"Ma","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2025.108015_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113787","article-title":"Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin","volume":"174","author":"Bahrambeigi","year":"2020","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.phrs.2025.108015_bib92","first-page":"35","article-title":"Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response","volume":"16","author":"Dabi","year":"2022","journal-title":"Biol. Vol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2025.108015_bib94","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007235","article-title":"Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer","volume":"11","author":"Akce","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2025.108015_bib95","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2025.108015_bib96","doi-asserted-by":"crossref","first-page":"1281744","DOI":"10.3389\/fimmu.2023.1281744","article-title":"Readily available drugs and other interventions to potentially improve the efficacy of immune checkpoint blockade in cancer","volume":"14","author":"Coleman","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-025-07636-7","article-title":"Addition of metformin to anti-PD-1\/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients","volume":"16","author":"Amato","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2025.108015_bib98","article-title":"Metformin combining PD-1 inhibitor enhanced anti-tumor efficacy in STK11 mutant lung cancer through AXIN-1-dependent inhibition of STING ubiquitination","volume":"9","author":"Wang","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"9_ement","key":"10.1016\/j.phrs.2025.108015_bib99","article-title":"Abstract PO1-25-12: Metformin enhances response to chemotherapy combined with immunotherapy in a triple negative breast cancer in vivo model","volume":"84","author":"Zamora","year":"2024","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-25065-w","article-title":"Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model","volume":"12","author":"Abdelmoneim","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02273-w","article-title":"Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy","volume":"41","author":"Liu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib102","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s00262-020-02703-8","article-title":"Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)","volume":"70","author":"Kim","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib103","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108015_bib104","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.2147\/IJGM.S495449","article-title":"Clinical effect of treatment with metformin for type 2 diabetes on non-small cell lung cancer patients undergoing immunotherapy: a retrospective study","volume":"17","author":"Wang","year":"2024","journal-title":"Int. J. Gen. Med."},{"issue":"10","key":"10.1016\/j.phrs.2025.108015_bib105","doi-asserted-by":"crossref","first-page":"S261","DOI":"10.1016\/j.jtho.2024.09.469","article-title":"P2.11A.20 metformin enhances immune checkpoint inhibitor response in overweight lung cancer patients: a retrospective cohort study","volume":"19","author":"Kalvapudi","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.phrs.2025.108015_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112243","article-title":"Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors","volume":"134","author":"Shen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2025.108015_bib107","article-title":"Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharm."},{"key":"10.1016\/j.phrs.2025.108015_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122052","article-title":"Metformin-containing hydrogel scaffold to augment CAR-T therapy against post-surgical solid tumors","volume":"295","author":"Chao","year":"2023","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib109","doi-asserted-by":"crossref","first-page":"S396","DOI":"10.1016\/j.jtct.2023.12.557","article-title":"Metformin and cytokine release syndrome after immune effector cell therapy","volume":"30","author":"Mammadzadeh","year":"2024","journal-title":"Transplant. Cell. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2025.108015_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177141","article-title":"Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment","volume":"9","author":"Hatae","year":"2024","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2025.108015_bib112","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/OTT.S154853","article-title":"Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells","volume":"11","author":"Mu","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.phrs.2025.108015_bib113","first-page":"286","article-title":"Activation of CD8 T Lymphocytes during Viral Infections","volume":"4","author":"Sigal","year":"2016","journal-title":"Encycl. Immunobiol."},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib114","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/nar\/gkv047","article-title":"Regulation of mammalian nucleotide metabolism and biosynthesis","volume":"43","author":"Lane","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib116","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2025.108015_bib117","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib118","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-022-00381-1","article-title":"5-Methoxyflavone-induced AMPK\u03b1 activation inhibits NF-\u03baB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo","volume":"27","author":"Yang","year":"2022","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib119","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4155\/tde-2020-0102","article-title":"Role of metformin in various pathologies: State-of-the-art microcapsules for improving its pharmacokinetics","volume":"11","author":"Gedawy","year":"2020","journal-title":"Ther. Deliv."},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3803\/EnM.2014.29.4.553","article-title":"Activation of AMP-activated protein kinase attenuates tumor necrosis factor-\u03b1-induced lipolysis via protection of perilipin in 3T3-L1 adipocytes","volume":"29","author":"Hong","year":"2014","journal-title":"Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib121","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/ciae159","article-title":"Favorable antiviral effect of metformin on SARS-CoV-2 viral load in a randomized, placebo-controlled clinical trial of COVID-19","volume":"79","author":"Bramante","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.phrs.2025.108015_bib122","article-title":"Metformin modulates T cell function and alleviates liver injury through bioenergetic regulation in viral hepatitis","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib123","first-page":"1","article-title":"The diversity of CD8+ T cell dysfunction in cancer and viral infection","author":"Galluzzi","year":"2025","journal-title":"Nat. Rev. Immunol. 2025"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib124","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-023-00343-x","article-title":"The effect of metformin on influenza vaccine responses in nondiabetic older adults: a pilot trial","volume":"20","author":"Martin","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.phrs.2025.108015_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110692","article-title":"Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus","volume":"200","author":"Yen","year":"2023","journal-title":"Diabetes Res. Clin. Pr."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-60213-0","article-title":"Metformin-induced suppression of IFN-\u03b1 via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in type 2 diabetes","volume":"10","author":"Saenwongsa","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib127","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/aid.2020.0172","article-title":"Effects of brief adjunctive metformin therapy in virologically suppressed HIV-infected adults on polyfunctional HIV-specific CD8 T cell responses to PD-L1 blockade","volume":"37","author":"Chew","year":"2021","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"APR","key":"10.1016\/j.phrs.2025.108015_bib128","article-title":"The emerging epigenetic role of CD8+T cells in autoimmune diseases: a systematic review","volume":"10","author":"Deng","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2025.108015_bib129","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13133","article-title":"Metabolic tissue-resident CD8+ T cells: a key player in obesity-related diseases","volume":"22","author":"Wang","year":"2021","journal-title":"Obes. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib130","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-53990-5","article-title":"A chronic pro-inflammatory environment contributes to the physiopathology of actinic lentigines","volume":"14","author":"Duval","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2025.108015_bib131","doi-asserted-by":"crossref","DOI":"10.4110\/in.2023.23.e41","article-title":"The role of CD4 T Cell Help in CD8 T cell differentiation and function during chronic infection and cancer","volume":"23","author":"Topchyan","year":"2023","journal-title":"Immune Netw."},{"issue":"6925","key":"10.1016\/j.phrs.2025.108015_bib132","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2025.108015_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653605","article-title":"Control of T cell metabolism by cytokines and hormones","volume":"12","author":"Bishop","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2025.108015_bib134","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"25","key":"10.1016\/j.phrs.2025.108015_bib135","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1073\/pnas.1203543109","article-title":"Regulation of innate CD8 + T-cell activation mediated by cytokines","volume":"109","author":"Freeman","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"MAR","key":"10.1016\/j.phrs.2025.108015_bib136","article-title":"\u201cImmunometabolic regulation of interleukin-17-producing T helper cells: uncoupling new targets for autoimmunity,\u201d","volume":"8","author":"Binger","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib137","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaci.2023.10.024","article-title":"Chemokine CCL19 promotes type 2 T-cell differentiation and allergic airway inflammation","volume":"153","author":"Nakano","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"51","key":"10.1016\/j.phrs.2025.108015_bib138","doi-asserted-by":"crossref","first-page":"25839","DOI":"10.1073\/pnas.1901639116","article-title":"Critical role for TRIM28 and HP1\u03b2\/\u03b3 in the epigenetic control of T cell metabolic reprograming and effector differentiation","volume":"116","author":"Gehrmann","year":"2019","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2025.108015_bib139","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.immuni.2021.06.007","article-title":"Transforming growth factor-\u03b2-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection","volume":"54","author":"Gabriel","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaci.2015.05.004","article-title":"RhoA orchestrates glycolysis for TH2 cell differentiation and allergic airway inflammation","volume":"137","author":"Yang","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2025.108015_bib141","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2025.108015_bib142","first-page":"1","article-title":"The source of dietary fat influences anti-tumour immunity in obese mice","volume":"3","author":"Kunkemoeller","year":"2025","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib143","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","article-title":"STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib144","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/imr.12849","article-title":"Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes","volume":"295","author":"Turbitt","year":"2020","journal-title":"Immunol. Rev."},{"issue":"10","key":"10.1016\/j.phrs.2025.108015_bib145","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac124","article-title":"T-cell Metabolism as interpreted in obesity-associated inflammation","volume":"163","author":"Bharath","year":"2022","journal-title":"Endocrinol"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib146","first-page":"1","article-title":"Metformin prevents diabetes development in type 1 diabetes models via suppression of mTOR and STAT3 signaling in immune cells","volume":"15","author":"Suzuki","year":"2025","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2025.108015_bib147","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","article-title":"Metformin suppresses systemic autoimmunity in roquinsan\/san mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3","volume":"198","author":"Lee","year":"2017","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2025.108015_bib148","article-title":"Metformin ameliorates inflammatory bowel disease by suppression of the stat3 signaling pathway and regulation of the between Th17\/Treg Balance","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib149","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","article-title":"Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis","volume":"16","author":"Kang","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2025.108015_bib150","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.4049\/jimmunol.0803563","article-title":"Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis","volume":"182","author":"Nath","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib151","doi-asserted-by":"crossref","unstructured":"L. P. Bharath and B. S. Nikolajczyk, \u201cThe intersection of metformin and inflammation,\u201d https:\/\/doi.org\/10.1152\/ajpcell.00604.2020, vol. 320, no. 5, pp. C873\u2013C879, May 2021, doi: 10.1152\/AJPCELL.00604.2020.","DOI":"10.1152\/ajpcell.00604.2020"},{"key":"10.1016\/j.phrs.2025.108015_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148648","article-title":"Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis","volume":"1822","author":"Gilbert","year":"2024","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.phrs.2025.108015_bib153","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41366-020-00692-3","article-title":"Targeting T-cell oxidative metabolism to improve influenza survival in a mouse model of obesity","volume":"44","author":"Alwarawrah","year":"2020","journal-title":"Int. J. Obes."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-7613(02)00338-2","article-title":"Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention","volume":"17","author":"Liblau","year":"2002","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.phrs.2025.108015_bib155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41590-021-00949-7","article-title":"Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity","volume":"22","author":"Collier","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2025.108015_bib156","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657768","article-title":"Emerging therapeutics for immune tolerance: tolerogenic vaccines, T cell therapy, and IL-2 therapy","volume":"12","author":"Moorman","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2025.108015_bib157","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2022.03.010","article-title":"Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD","volume":"77","author":"Wabitsch","year":"2022","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.phrs.2025.108015_bib158","doi-asserted-by":"crossref","first-page":"S438","DOI":"10.1016\/j.jtho.2023.09.799","article-title":"EP02.04-07 metformin enhances immune checkpoint inhibitor efficacy in an obesity-specific manner","volume":"18","author":"Yendamuri","year":"2023","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2025.108015_bib159","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41366-020-00692-3","article-title":"Targeting T-cell oxidative metabolism to improve influenza survival in a mouse model of obesity","volume":"44","author":"Alwarawrah","year":"2020","journal-title":"Int. J. Obes."},{"issue":"16","key":"10.1016\/j.phrs.2025.108015_bib160","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1158\/0008-5472.CAN-15-0454","article-title":"Rapamycin impairs antitumor CD8p T-cell responses and vaccine-induced tumor eradication","volume":"75","author":"Chaoul","year":"2015","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib161","doi-asserted-by":"crossref","DOI":"10.2217\/lmt-2018-0016","article-title":"Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors","volume":"8","author":"Afzal","year":"2019","journal-title":"Lung Cancer Manag"},{"issue":"4","key":"10.1016\/j.phrs.2025.108015_bib162","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.21873\/anticanres.14182","article-title":"Impact of concomitant medication administered at the time of initiation of nivolumab therapy on outcome in non-small cell lung cancer","volume":"40","author":"Svaton","year":"2020","journal-title":"Anticancer Res"},{"issue":"14","key":"10.1016\/j.phrs.2025.108015_bib163","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-22-3116","article-title":"Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer","volume":"29","author":"Cortellini","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.108015_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-54595-2","article-title":"Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years","volume":"15","author":"Neller","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib165","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41416-023-02204-2","article-title":"Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?","volume":"128","author":"Lord","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib166","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.immuni.2010.08.002","article-title":"Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1","volume":"33","author":"Zhou","year":"2010","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2025.108015_bib167","doi-asserted-by":"crossref","DOI":"10.4110\/in.2019.19.e11","article-title":"Metabolic reprogramming by the excessive AMPK activation exacerbates antigen-specific memory CD8+ T cell differentiation after acute lymphocytic choriomeningitis virus infection","volume":"19","author":"Son","year":"2019","journal-title":"Immune Netw."},{"issue":"6","key":"10.1016\/j.phrs.2025.108015_bib168","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00125-023-05898-4","article-title":"Significant impact of time-of-day variation on metformin pharmacokinetics","volume":"66","author":"T\u00fcrk","year":"2023","journal-title":"Diabetologia"},{"issue":"S3","key":"10.1016\/j.phrs.2025.108015_bib169","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dom.15749","article-title":"Optimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes,\u201d Diabetes","volume":"26","author":"Silverii","year":"2024","journal-title":"Obes. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2025.108015_bib170","doi-asserted-by":"crossref","first-page":"993","DOI":"10.7150\/thno.104872","article-title":"Metformin-based nanomedicines for reprogramming tumor immune microenvironment","volume":"15","author":"Liu","year":"2025","journal-title":"Theranostics"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825004402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:47:24Z","timestamp":1773280044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825004402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":170,"alternative-id":["S1043661825004402"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108015","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic modulation of CD8\u207a T cells by metformin: A promising adjuvant strategy for CD8\u207a T Cell-Based Immunotherapies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108015"}}